Benzinga's Top Upgrades, Downgrades For April 5, 2018

Top Upgrades

• Analysts at UBS upgraded Citigroup Inc. C from Neutral to Buy. Citigroup rose 1.59 percent to $70.38 in pre-market trading.
• Buckingham upgraded CarMax Inc. KMX from Neutral to Buy. CarMax shares rose 0.83 percent to $63.25 in pre-market trading.
• Wedbush upgraded AutoZone, Inc. AZO from Neutral to Outperform. AutoZone shares rose 1.52 percent to close at $628.65 on Wednesday.
• Loop Capital upgraded Tiffany & Co. TIF from Hold to Buy. Tiffany shares rose 3.45 percent to $99.89 in pre-market trading.
• JMP Securities upgraded Acuity Brands, Inc. AYI from Market Perform to Market Outperform. Acuity Brands shares fell 3.93 percent to close at $129.48 on Wednesday.
• Wells Fargo upgraded First Horizon National Corporation FHN from Market Perform to Outperform. First Horizon National shares rose 0.96 percent to close at $18.91 on Wednesday.
• UBS upgraded Wells Fargo & Company WFC from Neutral to Buy. Wells Fargo shares rose 1.21 percent to $53.54 in pre-market trading.
• Morgan Stanley upgraded Finisar Corporation FNSR from Equal-Weight to Overweight. Finisar shares rose 6.33 percent to $15.63 in pre-market trading.
• Stifel Nicolaus upgraded Advanced Micro Devices, Inc. AMD from Hold to Buy. AMD shares rose 2.87 percent to $10.05 in pre-market trading.
• Barclays upgraded Merck & Co., Inc. MRK from Equal-Weight to Overweight. Merck shares rose 1.15 percent to $55.18 in pre-market trading.

Top Downgrades

• Barclays downgraded Pfizer Inc. PFE from Overweight to Equal-Weight. Pfizer shares fell 0.36 percent to $36.00 in pre-market trading.
• Analysts at RBC Capital downgraded Johnson Controls International plc JCI from Sector Perform to Underperform. Johnson Controls shares fell 1.66 percent to $34.44 in pre-market trading.
• Stifel Nicolaus downgraded Intel Corporation INTC from Buy to Hold. Intel shares fell 0.26 percent to $49.86 in pre-market trading.
• Bank of America downgraded Ollie's Bargain Outlet Holdings, Inc. OLLI from Buy to Neutral. Ollie's Bargain Outlet shares fell 4.86 percent to $57.51 in pre-market trading.
• Barclays downgraded Biogen Inc. BIIB from Overweight to Equal-Weight. Biogen shares rose 2.22 percent to close at $272.40 on Wednesday.
• Barclays downgraded Biohaven Pharmaceutical Holding Company Ltd. BHVN from Overweight to Equal-Weight. Biohaven Pharmaceutical shares rose 0.20 percent to close at $25.15 on Wednesday.

Top Initiations

• UBS initiated coverage on Micron Technology, Inc. MU with a Sell rating. The price target for Micron is set to $35. Micron shares closed at $53.39 on Wednesday.
• Analysts at Chardan Capital initiated coverage on ProQR Therapeutics N.V. PRQR with a Buy rating. The price target for ProQR Therapeutics is set to $4.50. ProQR Therapeutics closed at $2.95 on Wednesday.
• B. Riley initiated coverage on Saul Centers, Inc. BFS with a Neutral rating. The price target for Saul Centers is set to $54. Saul Centers shares closed at $51.30 on Wednesday.
• Canaccord Genuity initiated coverage on Spotify Technology S.A. MFNC with a Buy rating. The price target for Spotify is set to $200. Spotify shares closed at $145.87 on Wednesday.
• Analysts at UBS initiated coverage on Broadcom Limited AVGO with a Buy rating. The price target for Broadcom is set to $350. Broadcom shares closed at $236.99 on Wednesday.
• Buckingham initiated coverage on Houlihan Lokey, Inc. HLI with a Buy rating. The price target for Houlihan Lokey is set to $54. Houlihan Lokey shares closed at $44.18 on Wednesday.
• Piper Jaffray initiated coverage on The Trade Desk, Inc. TTD with an Overweight rating. The price target for Trade Desk is set to $63. Trade Desk shares closed at $47.90 on Wednesday.
• Analysts at BTIG Research initiated coverage on Integra LifeSciences Holdings Corporation IART with a Neutral rating. The price target for Integra LifeSciences is set to $56. Integra LifeSciences shares closed at $56.00 on Wednesday.
• Analysts at KeyBanc Group initiated coverage on Baidu, Inc. BIDU with a Sector Weight rating. Baidu shares closed at $224.30 on Wednesday.
• UBS initiated coverage on NVIDIA Corporation NVDA with a Neutral rating. The price target for NVIDIA is set to $250. NVIDIA shares closed at $226.24 on Wednesday.